P6005 Master of Pharmaceutical Science

The course is structured in four parts:  Part A: Core foundation studies; Part B: Core case studies; Part C: Advanced studies; and Part D: Professional Practice.

Part A: Core foundation studies

This part consists of advanced preparatory studies and will equip you with the knowledge and skills base necessary for advanced studies in pharmaceutical science.

Part B: Core case studies

This part draws on a range of knowledge and laboratory-based case studies and scenarios to introduce you to advanced principles of pharmaceutical science.

Part C: Advanced studies

This part will allow you to develop your understanding of state of the art and emerging technologies in pharmaceutical sciences, and integrate this with career skills to prepare you for a professional placement.

Part D: Professional Practice

In this part, you will undertake a professional placement in the pharmaceutical or related industries or in a research laboratory, which gives you the opportunity to apply your knowledge and skills to solve contemporary problems in a workplace setting.

Master’s entry points

Depending on prior qualifications you may receive entry level credit (a form of block credit) which determines your point of entry to the course:

• If you are admitted at entry Level 1 you complete 96 credit points, comprising Part A (24 credit points), Part B (24 credit points), Part C (24 credit points) and Part D (24 credit points). (This entry point is available in Semester one only)
  
  
• If you are admitted at entry Level 2 you complete 72 credit points, comprising Part B (24 credit points), Part C (24 credit points) and Part D (24 credit points). (This entry point is available in Semester two only)
  
  
• If you are admitted at entry Level 3 you complete 48 credit points, comprising Part C (24 credit points) and Part D (24 credit points). (This entry point is available in Semester one only)

Note: If you are eligible for credit for prior studies you may elect not to receive the credit and complete one of the higher credit-point options.

Course progression map

The course progression map will provide guidance on unit enrolment for each semester of study.

The course comprises 96 points, structured into four parts: Part A: Core foundation studies (24 points), Part B: Core case studies (24 points), Part C: Advanced studies (24 points), and Part D: Professional Practice (24 points).

Units are 6 points unless otherwise stated.

Part A: Core foundation studies (24 points)

You must complete the following units:

• MPS5101 Overview of drug discovery and development
• MPS5102 Target identification and validation
• MPS5103 Drug design and optimisation
• MPS5104 Drug formulation, clinical trials and registration

Part B: Core case studies (24 points)

You must complete the following units:

• MPS5201 Drug stories: Lessons from the past and now
• MPS5202 From ideas to medicines: Investigator perspectives
• MPS5203 Experimental investigations: Learning from the lab
• MPS5204 Drug discovery and development: The next step

Part C: Advanced studies (24 points)

You must complete 18 points from the following units:

• MPS5301 State-of-the-art and emerging technologies
• MPS5303 Career tools: Bridging the gap
• MPS5304 Regulatory science and monitoring medicine use

You must complete 6 points from the following units:

• MPS5302 Contemporary pharmaceutical technologies
• MPS5305 Design and manufacture of mRNA therapeutics
• MON5750 Monash Innovation Guarantee

Part D: Professional Practice (24 points)

You must complete the following unit:

• MPS5401 Professional placement and research project (24 points)